Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Ferrari

Showing results (111-120 of 177) with videos related to

Pageof 18
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 10, 2018
Functional Performances on Admission Predict In-Hospital Falls, Injurious Falls, and Fractures in Older Patients: A Prospective StudyMélany Hars, Marie-Claude Audet, François Herrmann, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 3, 2012
Postmenopausal osteoporosis treatment with antiresorptives: effects of discontinuation or long-term continuation on bone turnover and fracture risk--a perspectiveSteven Boonen, Serge Ferrari, Paul D Miller, et al.
RMD Open|February 22, 2023
NADPH oxidase 4 deficiency attenuates experimental osteoarthritis in miceFélix Renaudin, Karim Oudina, Maude Gerbaix, et al.
The Lancet. Diabetes & Endocrinology|February 1, 2022
Bone fragility in diabetes: novel concepts and clinical implicationsLorenz C Hofbauer, Björn Busse, Richard Eastell, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 25, 2018
FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to DenosumabFelicia Cosman, Daria B Crittenden, Serge Ferrari, et al.
European Journal of Endocrinology|February 10, 2023
High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fractureFrancesca Marini, Francesca Giusti, Elena Marasco, et al.
The Journal of Clinical Endocrinology and Metabolism|May 25, 2019
Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab TreatmentSerge Ferrari, Peter W Butler, David L Kendler, et al.
Bone|February 25, 2020
Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observedSerge Ferrari, E Michael Lewiecki, Peter W Butler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 24, 2020
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5DPieter Evenepoel, John Cunningham, Serge Ferrari, et al.
Archives of Osteoporosis|November 2, 2016
Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fractureSerge Ferrari, Jean-Yves Reginster, Maria Luisa Brandi, et al.
Pageof 18

Showing results (111-120 of 177) with videos related to

Sort By:
Pageof 18
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 10, 2018
Functional Performances on Admission Predict In-Hospital Falls, Injurious Falls, and Fractures in Older Patients: A Prospective StudyMélany Hars, Marie-Claude Audet, François Herrmann, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 3, 2012
Postmenopausal osteoporosis treatment with antiresorptives: effects of discontinuation or long-term continuation on bone turnover and fracture risk--a perspectiveSteven Boonen, Serge Ferrari, Paul D Miller, et al.
RMD Open|February 22, 2023
NADPH oxidase 4 deficiency attenuates experimental osteoarthritis in miceFélix Renaudin, Karim Oudina, Maude Gerbaix, et al.
The Lancet. Diabetes & Endocrinology|February 1, 2022
Bone fragility in diabetes: novel concepts and clinical implicationsLorenz C Hofbauer, Björn Busse, Richard Eastell, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 25, 2018
FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to DenosumabFelicia Cosman, Daria B Crittenden, Serge Ferrari, et al.
European Journal of Endocrinology|February 10, 2023
High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fractureFrancesca Marini, Francesca Giusti, Elena Marasco, et al.
The Journal of Clinical Endocrinology and Metabolism|May 25, 2019
Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab TreatmentSerge Ferrari, Peter W Butler, David L Kendler, et al.
Bone|February 25, 2020
Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observedSerge Ferrari, E Michael Lewiecki, Peter W Butler, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 24, 2020
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5DPieter Evenepoel, John Cunningham, Serge Ferrari, et al.
Archives of Osteoporosis|November 2, 2016
Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fractureSerge Ferrari, Jean-Yves Reginster, Maria Luisa Brandi, et al.
Pageof 18